Kintegral Advisory
DGX icon

Kintegral Advisory’s Quest Diagnostics DGX Stock Holding History

Kintegral Advisory’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.81M Buy
12,052
+68
+0.6% +$15.7K 0.22% 101
2026
Q2 		$2.54M Hold
11,984
– – 0.21% 112
2026
Q1 		$2.35M Sell
11,984
-531
-4% -$103K 0.22% 109
2025
Q4 		$2.17M Sell
12,515
-343
-3% -$62.5K 0.18% 119
2025
Q3 		$2.45M Sell
12,858
-57
-0.4% -$10.1K 0.21% 114
2025
Q2 		$2.32M Sell
12,915
-20
-0.2% -$3.47K 0.21% 115
2025
Q1 		$2.19M Sell
12,935
-43
-0.3% -$7.06K 0.22% 115
2024
Q4 		$1.96M Sell
12,978
-605
-4% -$94.1K 0.18% 126
2024
Q3 		$2.11M Sell
13,583
-178
-1% -$26.6K 0.19% 127
2024
Q2 		$1.88M Buy
13,761
+2,374
+21% +$325K 0.18% 127
2024
Q1 		$1.52M Sell
11,387
-35
-0.3% -$4.54K 0.15% 132
2023
Q4 		$1.57M Sell
11,422
-72
-0.6% -$9.47K 0.17% 128
2023
Q3 		$1.4M Sell
11,494
-7
-0.1% -$933 0.17% 128
2023
Q2 		$1.62M Hold
11,501
– – 0.19% 118
2023
Q1 		$1.63M Sell
11,501
-618
-5% -$88.4K 0.21% 118
2022
Q4 		$1.9M Sell
12,119
-623
-5% -$89.5K 0.25% 116
2022
Q3 		$1.56M Hold
12,742
– – 0.22% 114
2022
Q2 		$1.69M Buy
12,742
+270
+2% +$36.8K 0.22% 109
2022
Q1 		$1.71M Buy
12,472
+279
+2% +$38.9K 0.19% 116
2021
Q4 		$2.11M Hold
12,193
– – 0.22% 110
2021
Q3 		$1.77M Hold
12,193
– – 0.21% 116
2021
Q2 		$1.61M Hold
12,193
– – 0.19% 124
2021
Q1 		$1.56M Hold
12,193
– – 0.2% 121
2020
Q4 		$1.45M Hold
12,193
– – 0.2% 122
2020
Q3 		$1.4M Sell
12,193
-392
-3% -$46.3K 0.21% 110
2020
Q2 		$1.43M Hold
12,585
– – 0.23% 103
2020
Q1 		$1.01M Buy
12,585
+1,408
+13% +$146K 0.2% 123
2019
Q4 		$1.19M Hold
11,177
– – 0.22% 119
2019
Q3 		$1.2M Hold
11,177
– – 0.24% 116
2019
Q2 		$1.14M Hold
11,177
– – 0.23% 122
2019
Q1 		$1M Buy
11,177
+8,661
+344% +$751K 0.21% 121
2018
Q4 		$210K Buy
+2,516
New +$236K 0.06% 218

Other funds holding DGX

Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Eastern Bank
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
Braun Stacey Associates
Braun Stacey Associates New York $3.48B AUM 48.73% 1-Year Est. Return
Copeland Capital Management
Copeland Capital Management Conshohocken, Pennsylvania $4.34B AUM 17.52% 1-Year Est. Return
Boston Common Asset Management
Boston Common Asset Management Boston, Massachusetts $1.72B AUM 26.04% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
JGP Wealth Management
JGP Wealth Management Bend, Oregon $1.13B AUM 26% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

Kintegral Advisory's DGX Position: Q3 2026 in Review

Kintegral Advisory increased its Quest Diagnostics (DGX) stake by 0.57% in Q3 2026, buying an estimated $15.7K and bringing the position to 12,052 shares worth $2.81M. The position accounts for 0.22% of the portfolio, ranked #101.

Kintegral Advisory first reported a position in DGX in Q4 2018 and has held it in 32 quarters since. 165 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • Kintegral Advisory held 12,052 shares of Quest Diagnostics worth $2.81M as of Q3 2026.
  • Kintegral Advisory bought 68 Quest Diagnostics shares in Q3 2026, an estimated $15.7K.
  • Quest Diagnostics made up 0.22% of Kintegral Advisory's portfolio in Q3 2026, its #101 holding.
  • Kintegral Advisory first reported a position in Quest Diagnostics in Q4 2018 and has held it in 32 quarters since.
  • 165 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Kintegral Advisory's 13F filing for Q3 2026, filed 16 Oct 2026.